Another earlier memantine trial – the Benefit and Efficacy in Severely Demented patients during Treatment with Memantine (M-Best or 9403) study – enrolled participants with moderately severe ...

Memantine HCl 2mg/mL; sugar-and alcohol-free; peppermint flavor. Tabs—60; Titration Pak (28 x 5mg + 21 x 10mg)—1; Oral soln—contact supplier; XR caps 7mg, 21mg—30; 14mg, 28mg—30 ...

A new study suggests that a treatment for Alzheimer's, the most common type of dementia, can also treat the second most ...

The lifetime risk of developing Alzheimer’s at age 45 is 1 in 5 for women and 1 in 10 for men, according to the Alzheimer’s ...

Perceptual inference requires the integration of visual features through recurrent processing, the dynamic exchange of information between higher and lower level cortical regions. While animal ...

Alzheimer’s is now the 6th leading cause of death among adults 65 years or older. The progressive condition, characterised by ...

Nystagmus is characterized by involuntary to and fro movement of the eyes. There is evidence to indicate that memantine and gabapentin can reduce acquired nystagmus, but these drugs have not been ...

“There are currently no approved treatments for DLB, so doctors often use drugs for Alzheimer’s disease, such as cholinesterase inhibitors and memantine, for symptom relief,” says Hong ...

The first treatment was a cholinesterase inhibitor called donepezil, and the second treatment was memantine. All participants were diagnosed and started treatment within three months of diagnosis ...

There are four medications approved in the UK to ease a person’s dementia symptoms, including memory and thinking problems: donepezil rivastigmine galantamine memantine. These treatments are only ...

Anton P Porsteinsson has received grant or research support from Baxter, Bristol-Myers Squibb, Eisai, Elan, Janssen Alzheimer Initiative, Medivation, Pfizer, Toyama and Wyeth. He has served as a ...